KIT and gastrointestinal stromal tumor: In GIST activating mutations in c-KIT exons 8, 9, 11, 13 and 17 are found in 75–80% of cases, mutations in PDGFRA exons 12, 14 and 18 in 5–8%, and they are mutually exclusive (for review [9]).